216 related articles for article (PubMed ID: 26852160)
1. Pharmacokinetics of 21 active components in focal cerebral ischemic rats after oral administration of the active fraction of Xiao-Xu-Ming decoction.
Wang C; Jia Z; Wang Z; Hu T; Qin H; Du G; Wu C; Zhang J
J Pharm Biomed Anal; 2016 Apr; 122():110-7. PubMed ID: 26852160
[TBL] [Abstract][Full Text] [Related]
2. Rapid identification and analysis of the active components of traditional Chinese medicine Xiaoxuming decoction for ischemic stroke treatment by integrating UPLC-Q-TOF/MS and RRLC-QTRAP MS
Luo X; Chen X; Shen X; Yang Z; Du G
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():313-322. PubMed ID: 31269467
[TBL] [Abstract][Full Text] [Related]
3. Identification of active compounds and their metabolites by high-performance liquid chromatography/electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry from Xiao-xu-ming decoction (XXMD).
Wang Y; Ding C; Du K; Xiao Y; Wu C; Zhang J; Qin H; Du G
Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2724-32. PubMed ID: 19639616
[TBL] [Abstract][Full Text] [Related]
4. Xiao-Xu-Ming decoction preserves mitochondrial integrity and reduces apoptosis after focal cerebral ischemia and reperfusion via the mitochondrial p53 pathway.
Lan R; Zhang Y; Xiang J; Zhang W; Wang GH; Li WW; Xu LL; Cai DF
J Ethnopharmacol; 2014; 151(1):307-16. PubMed ID: 24189031
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of xiao-xu-ming decoction against ischemic neuronal injury in vivo and in vitro.
Zhu XH; Li SJ; Hu HH; Sun LR; Das M; Gao TM
J Ethnopharmacol; 2010 Jan; 127(1):38-46. PubMed ID: 19800960
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics-based study of the potential interventional effects of Xiao-Xu-Ming Decoction on cerebral ischemia/reperfusion rats.
Wu Z; Qian S; Zhao L; Zhang Z; Song C; Chen L; Gao H; Zhu W
J Ethnopharmacol; 2022 Sep; 295():115379. PubMed ID: 35595221
[TBL] [Abstract][Full Text] [Related]
7. Xiao-Xu-Ming decoction prevented hemorrhagic transformation induced by acute hyperglycemia through inhibiting AGE-RAGE-mediated neuroinflammation.
Liu N; Liu C; Yang Y; Ma G; Wei G; Liu S; Kong L; Du G
Pharmacol Res; 2021 Jul; 169():105650. PubMed ID: 33964468
[TBL] [Abstract][Full Text] [Related]
8. An Integrated Approach for Studying Exposure, Metabolism, and Disposition of Multiple Component Herbal Medicines Using High-Resolution Mass Spectrometry and Multiple Data Processing Tools.
Wu C; Zhang H; Wang C; Qin H; Zhu M; Zhang J
Drug Metab Dispos; 2016 Jun; 44(6):800-8. PubMed ID: 27013399
[TBL] [Abstract][Full Text] [Related]
9. Induced cortical neurogenesis after focal cerebral ischemia--Three active components from Huang-Lian-Jie-Du Decoction.
Zou H; Long J; Zhang Q; Zhao H; Bian B; Wang Y; Zhang J; Zhao H; Wang L
J Ethnopharmacol; 2016 Feb; 178():115-24. PubMed ID: 26657578
[TBL] [Abstract][Full Text] [Related]
10. Xiao-Xu-Ming Decoction Reduced Mitophagy Activation and Improved Mitochondrial Function in Cerebral Ischemia and Reperfusion Injury.
Lan R; Zhang Y; Wu T; Ma YZ; Wang BQ; Zheng HZ; Li YN; Wang Y; Gu CQ; Wu JT
Behav Neurol; 2018; 2018():4147502. PubMed ID: 30018669
[TBL] [Abstract][Full Text] [Related]
11. Xiaoxuming Decoction Regulates Vascular Function by Modulating G Protein-Coupled Receptors: A Molecular Docking Study.
Shen Y; Yang R; Zhou R; Lu W; Li L; Niu Z; Chen M; Wang J; Wang Y; Fang L; Du G
Biomed Res Int; 2021; 2021():5575443. PubMed ID: 34195269
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology-Based Analysis of Xiao-Xu-Ming Decoction on the Treatment of Alzheimer's Disease.
Shen Y; Zhang B; Pang X; Yang R; Chen M; Zhao J; Wang J; Wang Z; Yu Z; Wang Y; Li L; Liu A; Du G
Front Pharmacol; 2020; 11():595254. PubMed ID: 33390981
[TBL] [Abstract][Full Text] [Related]
13. Xiao-Xu-Ming Decoction Protects against Blood-Brain Barrier Disruption and Neurological Injury Induced by Cerebral Ischemia and Reperfusion in Rats.
Lan R; Xiang J; Wang GH; Li WW; Zhang W; Xu LL; Cai DF
Evid Based Complement Alternat Med; 2013; 2013():629782. PubMed ID: 23710225
[TBL] [Abstract][Full Text] [Related]
14. Perturbed Lipidomic Profiles in Rats With Chronic Cerebral Ischemia Are Regulated by Xiao-Xu-Ming Decoction.
Jia Z; Tie C; Wang C; Wu C; Zhang J
Front Pharmacol; 2019; 10():264. PubMed ID: 30941043
[TBL] [Abstract][Full Text] [Related]
15. A Network Pharmacology-Based Identification Study on the Mechanism of Xiao-Xu-Ming Decoction for Cerebral Ischemic Stroke.
Li DH; Su YF; Sun CX; Fan HF; Gao WJ
Evid Based Complement Alternat Med; 2020; 2020():2507074. PubMed ID: 33133212
[TBL] [Abstract][Full Text] [Related]
16. [Effects of active components group of Xiaoxuming decoction on brain mitochondria in cerebral ischemia/reperfusion rats during early recovery period].
Du X; Lu C; He XL; Du GH
Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(11):2139-2145. PubMed ID: 28822160
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic Study of Piracetam in Focal Cerebral Ischemic Rats.
Paliwal P; Dash D; Krishnamurthy S
Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):205-213. PubMed ID: 28916907
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics of puerarin, daidzin, baicalin, glycyrrhizic acid, liquiritin, berberine, palmatine and jateorhizine by liquid chromatography-mass spectrometry after oral administration of Gegenqinlian decoction and active components alignment (ACA) to rats.
Xu B; Li P; Zhang G
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():33-44. PubMed ID: 25746576
[TBL] [Abstract][Full Text] [Related]
19. Detecting Key Functional Components Group and Speculating the Potential Mechanism of Xiao-Xu-Ming Decoction in Treating Stroke.
Chen YP; Wang KX; Cai JQ; Li Y; Yu HL; Wu Q; Meng W; Wang HD; Yin CH; Wu J; Huang MB; Li R; Guan DG
Front Cell Dev Biol; 2022; 10():753425. PubMed ID: 35646921
[TBL] [Abstract][Full Text] [Related]
20. Protective Effect of Xiao-Xu-Ming Decoction-Mediated Inhibition of ROS/NLRP3 Axis on Lipopolysaccharide-Induced Acute Lung Injury
Xiang Y; Cai M; Li X; Bao X; Cai D
Evid Based Complement Alternat Med; 2021; 2021():8257495. PubMed ID: 34616481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
